Skip to Main Content

Author Details

Eberhard Schlatter
University Hospital Muenster
1979
170
49
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34099798Unexpected localization of AQP3 and AQP4 induced by migration of primary cultured IMCD cells.Sci Rep2021
30273596Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts.J Invest Dermatol2019
31493026An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection.Arch Toxicol2019
28031320Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules.FASEB J2017
28689374Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.Clin Transl Sci2017
28709641GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.Kidney Int2017
25919412Noninvasive Imaging of Acute Renal Allograft Rejection by Ultrasound Detection of Microbubbles Targeted to T-lymphocytes in Rats.Ultraschall Med2016
26613381Renal Contrast-Enhanced Sonography Findings in a Model of Acute Cellular Allograft Rejection.Am J Transplant2016
27635733MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients.Blood Cancer J2016
27464968The kidney-specific expression of genes can be modulated by the extracellular osmolality.FASEB J2016
26979622A phosphotyrosine switch regulates organic cation transporters.Nat Commun2016
25500123Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC/TERT1.Toxicol In Vitro2015
25848011Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions.Proc Natl Acad Sci U S A2015
25823781Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.Pharmacogenomics2015
23982114The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.Pflugers Arch2014
24916697Cisplatin-induced renal injury is independently mediated by OCT2 and p53.Clin Cancer Res2014
24691693[End-stage renal disease after sarcoma therapy - case 3/2014].Dtsch Med Wochenschr2014
24476694The calcium-activated chloride channel Anoctamin 1 contributes to the regulation of renal function.Kidney Int2014
24233562Mouse organic cation transporter 1 determines properties and regulation of basolateral organic cation transport in renal proximal tubules.Pflugers Arch2014
23670903PET with 18F-FDG-labeled T lymphocytes for diagnosis of acute rat renal allograft rejection.J Nucl Med2013
23607617Kidney transplantation down-regulates expression of organic cation transporters, which translocate β-blockers and fluoroquinolones.Mol Pharm2013
23644348Non-invasive imaging of acute allograft rejection after rat renal transplantation using 18F-FDG PET.J Vis Exp2013
22085643The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization.FASEB J2012
23434854Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations.Nephron Physiol2012
23284953Transport mechanisms and their pathology-induced regulation govern tyrosine kinase inhibitor delivery in rheumatoid arthritis.PLoS One2012
22759973Regulation of organic cation transport in isolated mouse proximal tubules involves complex changes in protein trafficking and substrate affinity.Cell Physiol Biochem2012
22223530Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.Clin Cancer Res2012
21077648New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2.Mol Pharm2011
22031832Hydroxyfasudil-mediated inhibition of ROCK1 and ROCK2 improves kidney function in rat renal acute ischemia-reperfusion injury.PLoS One2011
21773745Different effects of CsA and FK506 on aquaporin-2 abundance in rat primary cultured collecting duct cells.Pflugers Arch2011
21553234LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment.Cell Mol Life Sci2011
21523352Properties and regulation of organic cation transport in freshly isolated mouse proximal tubules analyzed with a fluorescence reader-based method.Pflugers Arch2011
21327781Mechanisms of cell polarity and aquaporin sorting in the nephron.Pflugers Arch2011
20110413Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.Am J Pathol2010
21220920Cyclosporin-A induced toxicity in rat renal collecting duct cells: interference with enhanced hypertonicity induced apoptosis.Cell Physiol Biochem2010
20847180Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency.J Nucl Med2010
20176611IF/TA-related metabolic changes--proteome analysis of rat renal allografts.Nephrol Dial Transplant2010
19570884Atrial natriuretic peptide and nitric oxide signaling antagonizes vasopressin-mediated water permeability in inner medullary collecting duct cells.Am J Physiol Renal Physiol2009
19390685Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET.PLoS One2009
19330287Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent.Cell Mol Life Sci2009
17981899Translocation of aquaporin-containing vesicles to the plasma membrane is facilitated by actomyosin relaxation.Biophys J2008
18773185Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.J Mol Med (Berl)2008
18622612Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats.Eur J Nucl Med Mol Imaging2008
18261221Activation of counter-regulatory mechanisms in a rat renal acute rejection model.BMC Genomics2008
18216318Acute rejection modulates gene expression in the collecting duct.J Am Soc Nephrol2008
18335234Protective role of NHE-3 inhibition in rat renal transplantation undergoing acute rejection.Pflugers Arch2008
17143065Renal electrolyte effects of guanylin and uroguanylin.Curr Opin Nephrol Hypertens2007
17595527Ligands and signaling of the G-protein-coupled receptor GPR14, expressed in human kidney cells.Cell Physiol Biochem2007
16382016Cellular effects of guanylin and uroguanylin.J Am Soc Nephrol2006
17021264Who Wins the Competition: TRPV5 or Calbindin-D28K?J Am Soc Nephrol2006
  • 1 - 50 of 170

Recommended Authors

Ganesh Pathare
Institute of Anatomy, University of Zurich
Career Start Year 2011
Number of shared co-authors 1
Juan Pablo Arroyo
National Research Council of Canada
Career Start Year 2011
Number of shared co-authors 0
Yoskaly Lazo-Fernandez
Center for Precision Medicine, University of Missouri
Career Start Year 2011
Number of shared co-authors 0
Robert S Hoover
Tulane University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Wei Wu
University of California
Career Start Year 1996
Number of shared co-authors 0
Clara E Magyar
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Stefan Gr??nder
Institute of Physiology, RWTH Aachen University
Career Start Year 1991
Number of shared co-authors 0
Miguel A Valverde
Universitat Pompeu Fabra
Career Start Year 1991
Number of shared co-authors 0
Chao-Ling Yang
Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 0
Robert J Walker
University of Otago
Career Start Year 1991
Number of shared co-authors 0
Alan S L Yu
The Jared Grantham Kidney Institute, University of Kansas Medical Center
Career Start Year 1990
Number of shared co-authors 0
Olivier Devuyst
Institute of Physiology, University of Zurich, Cliniques Universitaires Saint-Luc
Career Start Year 1989
Number of shared co-authors 1
Sanjay K Nigam
university of california san diego
Career Start Year 1986
Number of shared co-authors 0
David M Cohen
Oregon Health and Science University
Career Start Year 1984
Number of shared co-authors 0
Raymond C Harris
Vanderbilt University Medical Center
Career Start Year 1984
Number of shared co-authors 0
David H Ellison
Oregon Health and Science University
Career Start Year 1982
Number of shared co-authors 1
Mark D Okusa
Division of Nephrology and Center for Immunity, University of Virginia
Career Start Year 1982
Number of shared co-authors 0
Susan M Wall
Emory University
Career Start Year 1981
Number of shared co-authors 0
Jill W Verlander
University of Florida
Career Start Year 1981
Number of shared co-authors 0
Jos?? M Fern??ndez-Fern??ndez
Universitat Pompeu Fabra
Career Start Year 1980
Number of shared co-authors 0
Bruce A Stanton
Dartmouth College
Career Start Year 1979
Number of shared co-authors 0
Seth L Alper
Beth Israel Deaconess Medical Center RN380F
Career Start Year 1978
Number of shared co-authors 0
Kathleen M Giacomini
University of California San Francisco
Career Start Year 1978
Number of shared co-authors 7
Daniele Cusi
Institute of Biomedical Technologies, National Research Council of Italy
Career Start Year 1978
Number of shared co-authors 0
Detlef Schl??ndorff
Icahn School of Medicine at Mount Sinai
Career Start Year 1976
Number of shared co-authors 0
Joseph V Bonventre
Brigham & Women's Hospital
Career Start Year 1975
Number of shared co-authors 0
Mark Donowitz
Johns Hopkins University School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Iekuni Ichikawa
Shinshu University
Career Start Year 1974
Number of shared co-authors 0
David S Miller
National Institutes of Health/National Institute of Environmental Health Sciences
Career Start Year 1971
Number of shared co-authors 0
Pavel Hamet
Montreal University Hospital Research Center
Career Start Year 1967
Number of shared co-authors 0

Collaborators

Hermann Pavenstädt
Co-authored papers 34
Giuliano Ciarimboli
University Hospital Munster
Co-authored papers 30
Ana Velic
Interfaculty Institute for Cell Biology.
Co-authored papers 9
Alex Sparreboom
Ohio State University
Co-authored papers 7
Jason A Sprowl
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Co-authored papers 6
Navjotsingh Pabla
The Ohio State University
Co-authored papers 4
Alice A Gibson
The Ohio State University
Co-authored papers 4
Lie Li
Sino-French Hoffmann Institute, Guangzhou Medical University
Co-authored papers 4
Thomas Pap
Co-authored papers 3
Markus M Rinschen
Co-authored papers 3
Shuiying Hu
The Ohio State University
Co-authored papers 3
Su Sien Ong
St. Jude Children's Research Hospital
Co-authored papers 2
Guido Cavaletti
NeuroMI (Milan Center for Neuroscience)
Co-authored papers 2
Guoqing Du
Second Affiliated Hospital of Harbin Medical University
Co-authored papers 2
Aksana Vasilyeva
St Jude Children's Research Hospital
Co-authored papers 2
Taosheng Chen
St. Jude Children's Research Hospital
Co-authored papers 2
Hartmut Schl??ter
University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Sharyn D Baker
Ohio State University
Co-authored papers 2
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Marianne Heitzmann
Co-authored papers 1
Robert B Diasio
Mayo Clinic
Co-authored papers 1
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 1
Colin A Johnson
University of Leeds Leeds Institute of Medical Research at St James's
Co-authored papers 1
Rachel A Ness
4Department of Pharmacy, Memphis Veterans Affairs Medical Center
Co-authored papers 1
Detlef Bockenhauer
Great Ormond Street Hospital for Children, NHS Foundation Trust
Co-authored papers 1
Ehud Y Isacoff
University of California berkeley
Co-authored papers 1
Anne T Nies
and University of Tuebingen, University of Tuebingen
Co-authored papers 1
Peter C M van Zijl
Johns Hopkins University School of Medicine
Co-authored papers 1
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 1
Release 1.2